Viewing Study NCT04772612


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2025-12-31 @ 9:30 PM
Study NCT ID: NCT04772612
Status: COMPLETED
Last Update Posted: 2023-10-23
First Post: 2021-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib
Sponsor: Mirati Therapeutics Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 516-012
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators